FDA Approves Unknown Drug — OUTLOOK THERAPEUTICS, INC.

**FDA Approval Granted to Outlook Therapeutics for BLA On July 24, 2026, the FDA granted approval to Outlook Therapeutics for BLA761320, a decision that the company anticipates will drive a significant market shift in the specific therapeutic area as the first approved commercial product within the segment. This regulatory milestone is expected to strategically accelerate the company's commercialization efforts and establish a dominant position amidst competitive dynamics in the upcoming fiscal quarter.**